277 related articles for article (PubMed ID: 32802845)
41. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
[TBL] [Abstract][Full Text] [Related]
42. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of lymphocyte surface markers in acute myeloid leukemia.
Ball ED; Davis RB; Griffin JD; Mayer RJ; Davey FR; Arthur DC; Wurster-Hill D; Noll W; Elghetany MT; Allen SL
Blood; 1991 May; 77(10):2242-50. PubMed ID: 1709379
[TBL] [Abstract][Full Text] [Related]
44. Decreased expression of DNAM-1 on NK cells from acute myeloid leukemia patients.
Sanchez-Correa B; Gayoso I; Bergua JM; Casado JG; Morgado S; Solana R; Tarazona R
Immunol Cell Biol; 2012 Jan; 90(1):109-15. PubMed ID: 21383766
[TBL] [Abstract][Full Text] [Related]
45. Selective recruitment of γδ T cells by a bispecific antibody for the treatment of acute myeloid leukemia.
Ganesan R; Chennupati V; Ramachandran B; Hansen MR; Singh S; Grewal IS
Leukemia; 2021 Aug; 35(8):2274-2284. PubMed ID: 33526858
[TBL] [Abstract][Full Text] [Related]
46. TIGIT blockade repolarizes AML-associated TIGIT
Brauneck F; Fischer B; Witt M; Muschhammer J; Oelrich J; da Costa Avelar PH; Tsoka S; Bullinger L; Seubert E; Smit DJ; Bokemeyer C; Ackermann C; Wellbrock J; Haag F; Fiedler W
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36549780
[TBL] [Abstract][Full Text] [Related]
47. PD-L1 Is Expressed and Promotes the Expansion of Regulatory T Cells in Acute Myeloid Leukemia.
Dong Y; Han Y; Huang Y; Jiang S; Huang Z; Chen R; Yu Z; Yu K; Zhang S
Front Immunol; 2020; 11():1710. PubMed ID: 32849603
[TBL] [Abstract][Full Text] [Related]
48. Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies.
Preillon J; Cuende J; Rabolli V; Garnero L; Mercier M; Wald N; Pappalardo A; Denies S; Jamart D; Michaux AC; Pirson R; Pitard V; Bagot M; Prasad S; Houthuys E; Brouwer M; Marillier R; Lambolez F; Marchante JR; Nyawouame F; Carter MJ; Baron-Bodo V; Marie-Cardine A; Cragg M; Déchanet-Merville J; Driessens G; Hoofd C
Mol Cancer Ther; 2021 Jan; 20(1):121-131. PubMed ID: 33277440
[TBL] [Abstract][Full Text] [Related]
49. Combined Blockade of TIGIT and CD39 or A2AR Enhances NK-92 Cell-Mediated Cytotoxicity in AML.
Brauneck F; Seubert E; Wellbrock J; Schulze Zur Wiesch J; Duan Y; Magnus T; Bokemeyer C; Koch-Nolte F; Menzel S; Fiedler W
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884723
[TBL] [Abstract][Full Text] [Related]
50. Anti-TIGIT differentially affects sepsis survival in immunologically experienced versus previously naive hosts.
Sun Y; Anyalebechi JC; Sun H; Yumoto T; Xue M; Liu D; Liang Z; Coopersmith CM; Ford ML
JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33682797
[TBL] [Abstract][Full Text] [Related]
51. Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD).
Battella S; Oliva S; Franchitti L; La Scaleia R; Soriani A; Isoldi S; Capuano C; Pighi C; Morrone S; Galandrini R; Santoni A; Palmieri G
Mucosal Immunol; 2019 Nov; 12(6):1358-1369. PubMed ID: 31582819
[TBL] [Abstract][Full Text] [Related]
52. TIGIT predominantly regulates the immune response via regulatory T cells.
Kurtulus S; Sakuishi K; Ngiow SF; Joller N; Tan DJ; Teng MW; Smyth MJ; Kuchroo VK; Anderson AC
J Clin Invest; 2015 Nov; 125(11):4053-62. PubMed ID: 26413872
[TBL] [Abstract][Full Text] [Related]
53. Immunoreceptor TIGIT inhibits the cytotoxicity of human cytokine-induced killer cells by interacting with CD155.
Zhang B; Zhao W; Li H; Chen Y; Tian H; Li L; Zhang L; Gao C; Zheng J
Cancer Immunol Immunother; 2016 Mar; 65(3):305-14. PubMed ID: 26842126
[TBL] [Abstract][Full Text] [Related]
54. Coexpression of TIGIT and FCRL3 identifies Helios+ human memory regulatory T cells.
Bin Dhuban K; d'Hennezel E; Nashi E; Bar-Or A; Rieder S; Shevach EM; Nagata S; Piccirillo CA
J Immunol; 2015 Apr; 194(8):3687-96. PubMed ID: 25762785
[TBL] [Abstract][Full Text] [Related]
55. Enhanced expression of TIGIT but not neuropilin-1 in patients with type 2 diabetes mellitus.
Hoseini-Aghdam M; Sheikh V; Eftekharian MM; Rezaeepoor M; Behzad M
Immunol Lett; 2020 Sep; 225():1-8. PubMed ID: 32540486
[TBL] [Abstract][Full Text] [Related]
56. TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer.
Beatson RE; Parente-Pereira AC; Halim L; Cozzetto D; Hull C; Whilding LM; Martinez O; Taylor CA; Obajdin J; Luu Hoang KN; Draper B; Iqbal A; Hardiman T; Zabinski T; Man F; de Rosales RTM; Xie J; Aswad F; Achkova D; Joseph CR; Ciprut S; Adami A; Roider HG; Hess-Stumpp H; Győrffy B; Quist J; Grigoriadis A; Sommer A; Tutt ANJ; Davies DM; Maher J
Cell Rep Med; 2021 Dec; 2(12):100473. PubMed ID: 35028614
[TBL] [Abstract][Full Text] [Related]
57. The TIGIT/CD226 axis regulates human T cell function.
Lozano E; Dominguez-Villar M; Kuchroo V; Hafler DA
J Immunol; 2012 Apr; 188(8):3869-75. PubMed ID: 22427644
[TBL] [Abstract][Full Text] [Related]
58. Targeting the "PVR-TIGIT axis" with immune checkpoint therapies.
Gorvel L; Olive D
F1000Res; 2020; 9():. PubMed ID: 32489646
[TBL] [Abstract][Full Text] [Related]
59. Hyperfunction of CD4 CD25 regulatory T cells in de novo acute myeloid leukemia.
Wan Y; Zhang C; Xu Y; Wang M; Rao Q; Xing H; Tian Z; Tang K; Mi Y; Wang Y; Wang J
BMC Cancer; 2020 May; 20(1):472. PubMed ID: 32456622
[TBL] [Abstract][Full Text] [Related]
60. DNAM-1 and the TIGIT/PVRIG/TACTILE Axis: Novel Immune Checkpoints for Natural Killer Cell-Based Cancer Immunotherapy.
Sanchez-Correa B; Valhondo I; Hassouneh F; Lopez-Sejas N; Pera A; Bergua JM; Arcos MJ; Bañas H; Casas-Avilés I; Durán E; Alonso C; Solana R; Tarazona R
Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31234588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
